These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18373560)

  • 1. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
    Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
    J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats.
    Kitamura Y; Watanabe S; Taguchi M; Takagi K; Kawata T; Takahashi-Niki K; Yasui H; Maita H; Iguchi-Ariga SM; Ariga H
    Mol Neurodegener; 2011 Jul; 6(1):48. PubMed ID: 21740546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol derivatives prevent oxidative stress-induced cell death in a DJ-1-dependent manner.
    Qu W; Fan L; Kim YC; Ishikawa S; Iguchi-Ariga SM; Pu XP; Ariga H
    J Pharmacol Sci; 2009 Jun; 110(2):191-200. PubMed ID: 19498271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
    Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
    Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
    Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
    Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
    Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
    Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DJ-1-Mediated protective effect of protocatechuic aldehyde against oxidative stress in SH-SY5Y cells.
    Gao JW; Yamane T; Maita H; Ishikawa S; Iguchi-Ariga SM; Pu XP; Ariga H
    J Pharmacol Sci; 2011; 115(1):36-44. PubMed ID: 21160133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DJ-1 binds to mitochondrial complex I and maintains its activity.
    Hayashi T; Ishimori C; Takahashi-Niki K; Taira T; Kim YC; Maita H; Maita C; Ariga H; Iguchi-Ariga SM
    Biochem Biophys Res Commun; 2009 Dec; 390(3):667-72. PubMed ID: 19822128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective function of DJ-1 in Parkinson's disease.
    Ariga H; Takahashi-Niki K; Kato I; Maita H; Niki T; Iguchi-Ariga SM
    Oxid Med Cell Longev; 2013; 2013():683920. PubMed ID: 23766857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DJ-1-binding compound B enhances Nrf2 activity through the PI3-kinase-Akt pathway by DJ-1-dependent inactivation of PTEN.
    Niki T; Endo J; Takahashi-Niki K; Yasuda T; Okamoto A; Saito Y; Ariga H; Iguchi-Ariga SMM
    Brain Res; 2020 Feb; 1729():146641. PubMed ID: 31891690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model.
    Jeong HJ; Kim DW; Woo SJ; Kim HR; Kim SM; Jo HS; Park M; Kim DS; Kwon OS; Hwang IK; Han KH; Park J; Eum WS; Choi SY
    Mol Cells; 2012 May; 33(5):471-8. PubMed ID: 22526393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
    Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC
    J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain.
    Yanagida T; Takata K; Inden M; Kitamura Y; Taniguchi T; Yoshimoto K; Taira T; Ariga H
    J Pharmacol Sci; 2006 Oct; 102(2):243-7. PubMed ID: 17038803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
    Ooe H; Iguchi-Ariga SM; Ariga H
    Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Function of DJ-1 in mitochondria].
    Takahashi-Niki K; Niki T; Iguchi-Ariga S; Ariga H
    Yakugaku Zasshi; 2012; 132(10):1105-10. PubMed ID: 23037695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients.
    Takahashi-Niki K; Niki T; Taira T; Iguchi-Ariga SM; Ariga H
    Biochem Biophys Res Commun; 2004 Jul; 320(2):389-97. PubMed ID: 15219840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
    Hijioka M; Inden M; Yanagisawa D; Kitamura Y
    Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.